CoChat

The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.

Autocrine and paracrine purinergic signaling in the most lethal types of cancer

Open access
Reyna-Jeldes, M., Díaz-Muñoz, M., Madariaga, J. A., Coddou, C., Vázquez-Cuevas, F. G. · 2021 · Purinergic Signalling

Abstract

Cancer comprises a collection of diseases that occur in almost any tissue and it is characterized by an abnormal and uncontrolled cell growth that results in tumor formation and propagation to other tissues, causing tissue and organ malfunction and death. Despite the undeniable improvement in cancer diagnostics and therapy, there is an urgent need for new therapeutic and preventive strategies with improved efficacy and fewer side effects. In this context, purinergic signaling emerges as an interesting candidate as a cancer biomarker or therapeutic target. There is abundant evidence that tumor cells have significant changes in the expression of purinergic receptors, which comprise the G-protein coupled P2Y and AdoR families of receptors and the ligand-gated ion channel P2X receptors. Tumor cells also exhibit changes in the expression of nucleotidases and other enzymes involved in nucleotide metabolism, and the concentrations of extracellular nucleotides are significantly higher than those observed in normal cells. In this review, we will focus on the potential role of purinergic signaling in the ten most lethal cancers (lung, breast, colorectal, liver, stomach, prostate, cervical, esophagus, pancreas, and ovary), which together are responsible for more than 5 million annual deaths.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11302-021-09785-8

Cites

211 of 211 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 206 references

Cited by

See all 27

Metadata

Authors
Reyna-Jeldes, M., Díaz-Muñoz, M., Madariaga, J. A., Coddou, C., & Vázquez-Cuevas, F. G.
Affiliations
Universidad Católica del Norte (CL)
Corresponding author
Coddou, C.
Venue
Purinergic Signalling
Published
2021-05-12
Volume
17
Issue
3
Pages
345-370
ISSN
  • 1573-9538 (ISSN-L)
  • 1573-9546
OpenAlex
W3160609839
Cited by
25
References
206
Citations by year
2026: 1 · 2025: 2 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 4
FWCI
0.86
Type
journal article
Language
en
Open access
Licence
Locations
  • Purinergic Signalling (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México (IN202620, IN202121)
  • Consejo Nacional de Ciencia y Tecnología (284557)
  • Fondo Nacional de Desarrollo Científico y Tecnológico (11614)
  • Programa de Equipamiento Científico y Tecnológico, Chile (EQM140100)
  • Millennium Nucleous for the Study of Pain
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
  • Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
Keywords
purinergic signaling, autocrine signaling, paracrine signaling, purinergic receptors, P2Y receptors, adenosine receptors, P2X receptors, nucleotidase, extracellular nucleotides, nucleotide metabolism, tumor markers, cancer therapy targets, lung cancer, breast cancer, colorectal cancer, liver cancer, gastric cancer, prostate cancer, cervical cancer, esophageal cancer, pancreatic cancer, ovarian cancer
MeSH terms
Adenosine Triphosphate, Animals, Humans, Neoplasms, Receptors, Purinergic, Signal Transduction, Autocrine Communication, Paracrine Communication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autocrine and paracrine purinergic signaling in the most lethal types of cancer. https://app.cochat.ai/papers/10.1007/s11302-021-09785-8
The paper
Reyna-Jeldes, M., Díaz-Muñoz, M., Madariaga, J. A., Coddou, C., & Vázquez-Cuevas, F. G. (2021). Autocrine and paracrine purinergic signaling in the most lethal types of cancer. Purinergic Signalling. https://doi.org/10.1007/s11302-021-09785-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.